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Abstract: Background: The hemoglobin threshold for transfusion of
red cells in patients with acute gastrointestinal bleeding is controver-
sial. We compared the efﬁcacy and safety of a restrictive transfusion
strategy with those of a liberal transfusion strategy.
Methods: We enrolled 921 patients with severe acute upper gastro-
intestinal bleeding and randomly assigned 461 of them to a restric-
tive strategy (transfusion when the hemoglobin level fell below
7 g per deciliter) and 460 to a liberal strategy (transfusion when
the hemoglobin fell below 9 g per deciliter). Randomization was
stratiﬁed according to the presence or absence of liver cirrhosis.
Results: A total of 225 patients assigned to the restrictive strategy
(51%), as compared with 61 assigned to the liberal strategy (14%),
did not receive transfusions (P <0.001) [corrected]. The probability
of survival at 6 weeks was higher in the restrictive-strategy group
than in the liberal-strategy group (95% vs. 91%; hazard ratio for
death with restrictive strategy, 0.55; 95% conﬁdence interval [CI],
0.33–0.92; P = 0.02). Further bleeding occurred in 10% of the patients
in the restrictive-strategy group as compared with 16% of the
patients in the liberal-strategy group (P = 0.01), and adverse events
occurred in 40% as compared with 48% (P = 0.02). The probability
of survival was slightly higher with the restrictive strategy than with
the liberal strategy in the subgroup of patients who had bleeding
associated with a peptic ulcer (hazard ratio, 0.70; 95% CI, 0.26–
1.25) and was signiﬁcantly higher in the subgroup of patients with
cirrhosis and Child-Pugh class A or B disease (hazard ratio, 0.30;
95% CI, 0.11–0.85), but not in those with cirrhosis and Child-Pugh
class C disease (hazard ratio, 1.04; 95% CI, 0.45–2.37). Within theJournal of Hepatology 20
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E-mail address: dominique.thabut@psl.aphp.fr (D. Thabut).ﬁrst 5 days, the portal-pressure gradient increased signiﬁcantly in
patients assigned to the liberal strategy (P = 0.03) but not in those
assigned to the restrictive strategy.
Conclusions: As compared with a liberal transfusion strategy, a
restrictive strategy signiﬁcantly improved outcomes in patients with
acute upper gastrointestinal bleeding. (Funded by Fundació Investi-
gació Sant Pau; ClinicalTrials.gov number, NCT00414713.)
 2013 European Association for the Study of the Liver. Published
by Elsevier B.V. Open access under CC BY-NC-ND license.Severe gastrointestinal bleeding often requires red blood transfu-
sions. Recommendations on when to transfuse have been based
on results of meta-analyses of randomized trials comparing
restrictive and liberal transfusion strategies and included very
few patients with gastrointestinal bleeding [1,2].
However, in an open-label trial conducted by Villanueva et al.
[3], 921 patients with upper gastrointestinal bleeding were ran-
domized to receive a restrictive transfusion strategy (when the
haemoglobin level was <7 g/dl) or a liberal strategy (when the
haemoglobin was <9 g/dl). All causes of bleeding were consid-
ered. Patients were stratiﬁed by presence of cirrhosis (inclusion
of 277 cirrhotic patients). The primary outcome was mortality
at day 45 and was signiﬁcantly lower in the restrictive than lib-
eral strategy group (5% vs. 9%, p = 0.02). Moreover, the risk of fur-
ther bleeding, length of hospital stay, need for rescue therapy,
overall rate of complications and rate of serious adverse events
were all signiﬁcantly reduced with the restrictive vs. liberal strat-
egy. These data strongly suggest that the restrictive strategy is
the best and should be used for upper gastrointestinal bleeding.
The beneﬁt of a restrictive strategy seemed particularly strong
in patients with Child-Pugh A/B cirrhosis.
Whether these results should be generalized to all patients
with gastrointestinal bleeding is matter of debate. Indeed, in
the Villanueva et al. study, patients were partly selected: (1)
2372 patients were admitted for gastrointestinal bleeding during
the study period, but only 1610 were screened and (2) patients
with the most severe condition (i.e., with massive exsanguina-
tion) at admission were excluded, as were patients at low risk
of re-bleeding. However, this study remains the ﬁrst in the ﬁeld
and provides data for recommendations for transfusion policy
in this setting.
The haemoglobin threshold for transfusion in cirrhotic
patients is controversial. The rationale for the restrictive
strategy is to prevent rebound increase in portal pressure [4].14 vol. 60 j 453–454
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Nevertheless, hypovolemia can lead to functional renal failure, a
strong predictor of mortality in patients with cirrhosis [5].
Cirrhotic patients at risk of death from gastrointestinal bleeding
are Child-Pugh C patients or patients with active bleeding at
endoscopy [6], that is, patients with high hepatic venous pressure
gradient (HVPG). In the Villanueva et al. trial, data for patients
with active bleeding at endoscopy are lacking. The restrictive
strategy had no effect on survival in Child-Pugh C patients. This
result might be due to the small sample size of Child-Pugh C
patients (55 patients). For about half of the cirrhotic patients
(n = 151), HVPG measurements were repeated, with no mention
of their Child-Pugh score. However, the mean HVGP was
20.1 ± 0.1 mmHg and 20.6 ± 5.2 mmHg respectively in the
restrictive and liberal strategy, highlighting the severity of portal
hypertension. Therefore, restrictive strategy seems to have a ben-
eﬁcial effect on survival in severe patients. Of note, in the restric-
tive-strategy group, HVPG did not decrease, despite somatostatin
treatment. This ﬁnding is not in accordance with results from
another study conducted by the same group, in which patients
received the same dose of somatostatin [7] and in which units
of red cells were administered to maintain haemoglobin level
at approximately 9 g/dl. The liberal strategy could have a delete-
rious effect in patients with less severe liver disease, and the rea-
son remains unsolved. The liberal strategy may lead to cardiac
decompensation because patients with cirrhosis often present
diastolic dysfunction [8]. Still, no data is available to evaluate
the frequency of cardiac decompensation related to a liberal
transfusion strategy.
Early transjugular intrahepatic portosystemic shunt (TIPS)
placement should considerably modify the prognosis of variceal
bleeders with severe cirrhosis (Child-Pugh C or B with active
bleeding) [9,10]. The rationale for this therapy is to stop bleeding
rapidly and prevent renal failure and other classical complica-
tions. In the present study, no patients underwent an early TIPS
strategy. Further studies regarding transfusion policy and ﬂuid
resuscitation are mandatory for patients who will beneﬁt from
early TIPS placement. Interestingly, in our prospective pilot study
of 35 consecutive non-selected patients with variceal bleeding
who underwent early TIPS, we observed more than 20% acute
cardiac failure after TIPS [10]. However, data regarding transfu-
sion policy have still to be analysed.
In conclusion, the restrictive transfusion strategy seems to be
signiﬁcantly superior to the liberal strategy in patients with454 Journal of Hepatology 201gastrointestinal bleeding, especially in patients with Child-Pugh
A/B cirrhosis. However, insufﬁcient data are available regarding
transfusion thresholds for high-risk patients, such as Child-Pugh
C patients or those patients who undergo early TIPS placement
after variceal bleeding. Further studies of these patients are
warranted.Conﬂict of interest
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